A detailed history of Cutler Group LP transactions in Bioventus Inc. stock. As of the latest transaction made, Cutler Group LP holds 4,800 shares of BVS stock, worth $56,208. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,800
Previous 4,800 -0.0%
Holding current value
$56,208
Previous $25,000 4.0%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$6.54 - $9.08 $353 - $490
-54 Reduced 1.11%
4,800 $33,000
Q1 2022

Apr 14, 2022

SELL
$11.65 - $15.28 $9,786 - $12,835
-840 Reduced 14.75%
4,854 $68,000
Q4 2021

Jan 18, 2022

BUY
$12.37 - $16.77 $70,434 - $95,488
5,694 New
5,694 $82,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $722M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.